Dealpath alternatives for CRE deal management

The main alternatives to Dealpath for commercial real estate deal management are MotionCRE, the sub-segment's published-price, self-serve entrant, and, for teams whose work centers on delivery rather than acquisitions, the development-management tools (Northspyre, Rabbet) that pick up where a pipeline ends. Which lane you are actually in decides the list. Pricing below was checked on vendor pages on August 20, 2026.

What does Dealpath do, and what does it cost?

Dealpath runs acquisition and disposition pipelines for institutional investors: deal tracking, workflow and approvals, data rooms, from sourcing through close. Its plans page lists Professional and Enterprise tiers with no numbers, states that "plans typically include a minimum of five users," and routes pricing to a demo request. Third-party aggregation has reported annual contracts from roughly $15,000 a year scaling with seats; treat that as an estimate, not a vendor figure.

What is the published-price alternative in the same lane?

MotionCRE, and it is worth being plain that it positions itself explicitly as a self-serve Dealpath alternative. Per its own comparison page, it publishes flat seat tiers: Team $249 a month for 3 seats, Plus $399 for 5 (extra seats $69), Power $699 for 10 (extra seats $59), with pipeline management, deal workspaces, data rooms, tiered file storage, and an AI assistant that summarizes documents, aimed at 2-to-15-person acquisition and development teams, with no long-term contract. For a small team that wants pipeline software this quarter at a knowable price, that is the honest first stop.

When is the pipeline category the wrong comparison?

When the pain starts after close. A pipeline tool's job largely ends when the deal becomes a project; budget variance, milestones, draws, and the portfolio roll-up belong to delivery and portfolio tools. In that lane the incumbents are Northspyre for cost automation and Rabbet for construction finance, both quote-only, and the working small-firm alternative remains the tracking spreadsheet.

Where does PlotSlate fit?

PlotSlate is being built as a development portfolio tracker that starts at sourcing: configurable pipeline stages with recorded transitions feed the same portfolio grid that tracks budget health, milestones, and blockers through closeout. It is not a dedicated acquisitions-pipeline product, and it is currently in development and not yet generally available, so it belongs on a watch list rather than in a bake-off; nothing here is an availability or purchase claim.

How should you choose?

Match the tool to the phase that hurts. Institutional acquisitions team with approvals and IC workflow: demo Dealpath and expect conversation pricing at a five-seat floor. Small team that needs pipeline now: MotionCRE's published tiers make it the measurable option. Post-close portfolio pain: shop the delivery category instead, and build the portfolio tracking discipline either way. The comparison hub is the index of the whole field, dated to the same landscape review.